DDX17 and gastric cancer: DDX17 is up-regulated in gastric cancer cells with acquired resistance to the combination of cisplatin and fluorouracil (CF) chemotherapy, and is identified as a pivotal gene in the protein-protein interaction network, which is closely related to the overall survival of patients (50).